MedPath

Titanium Platelet-rich Fibrin in Sinus Floor Elevation Through Flapless Transcrestal Approach

Not Applicable
Completed
Conditions
Sinus Floor Elevation
Interventions
Other: Flapless transcrestal sinus lift approach with TPRF
Other: Flapless transcrestal sinus lift approach with PRF
Registration Number
NCT05721612
Lead Sponsor
Hams Hamed Abdelrahman
Brief Summary

Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence flapless transcrestal sinus floor elevation is minimally invasive technique which is used in moderately defected maxilla.

Aim of the study: to evaluate both clinical and radiographic outcomes in sinus floor elevation following dental implant placement using flapless transcrestal sinus lift approach with Titanium platelet rich fibrin (TPRF) as a sole sinus graft material compared to Platelet rich fibrin (PRF).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Patient seeking replacement of a missed maxillary posterior teeth by a delayed dental implant procedure.
  • Residual bone height is (4-7) mm measured from crestal bone to sinus floor.
  • Good oral hygiene
Exclusion Criteria
  • Uncontrolled Diabetes.
  • Coagulation disorders.
  • Immunological disorders.
  • Previous radiation of the head and neck region.
  • Abnormal bone physiology.
  • Therapy with Bisphosphonates.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Study groupFlapless transcrestal sinus lift approach with TPRF-
Control gorupFlapless transcrestal sinus lift approach with PRF-
Primary Outcome Measures
NameTimeMethod
Change in bone densityBaseline and 6 months

Cuts of CBCT (cross sectional, axial and sagittal view), bone density, will be analyzed using On-demand software. The radiographic evaluation will be based on radiological parameters, using reference points and lines at T0 and T1.

Secondary Outcome Measures
NameTimeMethod
Change in implant stabilityBaseline and 6 months

Secondary implant stability will be measured 6 months post-operatively using Osstell device.

change in pain scores1st day, 3rd day and 1 week

Pain (by Visual Analogous Scale) ranges from 0 to 10 0 - No pain. 2 to 4 - Mild pain. 5 to 7 - Moderate pain. 8 to 10 - severe pain.

Trial Locations

Locations (1)

Alexandria Faculty of Dentistry

🇪🇬

Alexandria, Egypt

© Copyright 2025. All Rights Reserved by MedPath